Riskpilot← Back to searchSign inGet full accessNEMUS LILLESTRØM FYSIOTERAPI AS
ASActiveOrg 989638394Dampsagveien 2A, 2000 LillestrømPhysiotherapy activities · NACE 8695Est. 20060 employeeswww.romerike-fysioterapi.no
Revenue 2024
NOK 1,7M
+21% vs 2023
EBITDA margin
14.9%
+570% vs 2023
Equity ratio
37.5%
Financial strength
Net profit 2024
NOK -94K
+40% vs 2023
| Revenue | NOK 1,7M | +21% |
| EBITDA | NOK 259K | +570% |
| Net profit | NOK -94K | +40% |
| Total assets | NOK 1,2M | +57% |
| Equity | NOK 446K | -17% |
| Employees | 0 | — |
Legal name
NEMUS LILLESTRØM FYSIOTERAPI AS
Org number
989638394
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
6. april 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikling og drift av fysioterapivirksomhet samt framleie av lokaler og driftsmidler.
Address
Dampsagveien 2A, 2000 Lillestrøm
Website
www.romerike-fysioterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 689 | 1 458 | 1 508 | 1 444 | 1 741 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 442 | 132 | 76 | 39 | 259 |
| Depreciation & amort. | −235 | −234 | −234 | −239 | −241 |
| EBIT | 207 | −101 | −158 | −200 | 18 |
| Net financials | −21 | −5 | −0 | 0 | −1 |
| Profit before tax | 186 | −106 | −158 | −200 | 16 |
| Tax | 41 | −23 | −35 | −44 | 111 |
| Net profit | 145 | −82 | −123 | −156 | −94 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 277 | 1 085 | 876 | 758 | 1 190 |
| Equity | 902 | 820 | 697 | 541 | 446 |
| Long-term debt | 257 | 0 | 0 | 0 | 600 |
| Short-term debt | 118 | 265 | 180 | 217 | 144 |
| Total debt | 375 | 265 | 180 | 217 | 744 |
EBITDA margin
14.9%
This company
15.8%
Market median
-6% vs market
20202024
Equity ratio
37.5%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
-21.1%
This company
18.4%
Market median
-215% vs market
20202024
Net profit margin
-5.4%
This company
8.1%
Market median
-167% vs market
20202024
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20202024
Debt / equity
1.67×
This company
0.62×
Market median
-169% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HB Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEMUS LILLESTRØM FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Borgvang | Deputy Member | 0 companies |
| Espen Flemming Johannessen | Board of Directors | 0 companies |
| Jørund Sakshaug | Board of Directors | 0 companies |
| Anita Borgvang | Chairman | 0 companies |
| Linda Irene Linge | Board of Directors | 0 companies |